PTGS2 and colorectal cancer: In contrast to the wealth of data relating COX2 and colon cancer, there is little direct experimental evidence demonstrating that the expression/activity of COX2 or mPGES1 is causally linked to tumor progression and metastasis, in colorectal cancer.